In a pharmaceutical inspection, you must prove not just what your records say, but when they existed.

Completing and releasing batch manufacturing records (BMRs) for every production run.

Hash each BMR at the point of completion. Any subsequent change is detectable by mathematics, not by policy. The timestamp proves the record existed before any deviation or investigation was opened.

Typical remediation cost for a single data-integrity Form 483 observation: $500K–$2M. Warning letter escalation: $50M–$600M.

Generating and reviewing analytical results, chromatography data, and out-of-specification (OOS) investigations daily across QC labs.

Anchor raw data at the point of acquisition, satisfying ALCOA+ Original and Contemporaneous requirements independently of your LIMS audit trail, which is controlled by your own infrastructure.

A single invalidated batch, or a void OOS that restarts with falsified data, can wipe out a production run's revenue plus trigger import restrictions.

Capturing and locking clinical trial source data, electronic data capture records, and dataset snapshots across investigator sites and CROs.

Timestamp source data entries and dataset locks at the moment they occur across all sites. Provides independent, third-party-verifiable proof that the data was not altered after the trial concluded.

Average R&D investment per approved drug at risk: ~$2.6B. GVK Biosciences' ECG manipulation led to suspension of roughly 700 product authorisations across the EU.

Issuing new and revised standard operating procedures (SOPs) and recording staff training completions, continuously, at every manufacturing site.

Timestamp each SOP version at issuance and each training completion at the moment it is recorded. Proves the SOP in force at the time of any production run, and that training was completed before the relevant activity.

"Backdated training records" and "SOP not effective at time of manufacture" are among the most common and escalation-prone data-integrity findings at FDA, MHRA, and EMA inspections.

Logging deviations and opening CAPA investigations to meet internal and regulatory timeliness expectations.

Timestamp deviation logs at the moment of logging and CAPA openings at the moment of creation. Provides independently verifiable evidence that investigations were opened promptly, not reconstructed after the fact.

Provable investigation timing is required for batch disposition decisions. A finding that deviations were not contemporaneously recorded can void a batch release and trigger import-alert escalation.

Exchanging manufacturing data, analytical methods, specifications, and quality agreements with CROs, contract manufacturers (CMOs), and suppliers.

Hash every document exchanged at the moment of handoff. Creates a contemporaneous, independently verifiable record of exactly what each party held at each point in the transfer, without sharing the file itself.

Protects quality-agreement terms and know-how provenance when supplier or CMO relationships break down. Provides independent proof for regulatory submissions across multiple sites.

Pulling stability samples at defined timepoints and recording results to support shelf-life claims and marketing authorisation renewals.

Timestamp each stability result at the moment it is entered. Provides immutable evidence that results were recorded at the scheduled timepoint, not filled in retrospectively when timepoints were missed.

Retrospectively completed stability data is a direct route to a warning letter and can invalidate shelf-life extensions underpinning product launches worth tens of millions.

Producing and retaining validation documentation for computerised systems (LIMS, DCS, ERP, eDMS) to demonstrate ongoing qualification under Annex 11 and 21 CFR Part 11.

Timestamp validation deliverables (URS, IQ, OQ, PQ, periodic review reports) at the moment they are signed off. Independently proves the validation status of a system at any point in time, without relying on the system's own audit trail.

An inspector who cannot verify a system's validation history can place it out of service, halting production. Independent timestamps of validation evidence remove the ambiguity.